SGK3 and Global developmental delay: Together with observations from our and other labs showing that Sgk3-KO mice maintain normal growth, development, and adult metabolic parameters, with only transient developmental delays (28), these findings suggest SGK3 as a promising therapeutic target with a favorable safety profile.